(Q40326039)

19 September 2017

Syk tyrosine kinase mediates Epstein-Barr virus latent membrane protein 2A-induced cell migration in epithelial cells (English)

1 reference

19 September 2017

0 references

1 reference

4

Richard Longnecker

1 reference

19 September 2017

Jean Lu

1

1 reference

19 September 2017

Wan-Hsin Lin

2

1 reference

19 September 2017

Shao-Yin Chen

3

1 reference

19 September 2017

Shu-Chun Tsai

5

1 reference

19 September 2017

Chi-Long Chen

6

1 reference

19 September 2017

Ching-Hwa Tsai

7

1 reference

19 September 2017

language of work or name

English

0 references

publication date

23 January 2006

1 reference

Journal of Biological Chemistry

19 September 2017

1 reference

19 September 2017

281

1 reference

19 September 2017

8806-8814

1 reference

19 September 2017

13

1 reference

B cell signaling. Introduction

19 September 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507305200

Structure and function of Syk protein-tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507305200

Structural basis for Syk tyrosine kinase ubiquity in signal transduction pathways revealed by the crystal structure of its regulatory SH2 domains bound to a dually phosphorylated ITAM peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507305200

Anti-immunoglobulin stimulation of B lymphocytes activates src-related protein-tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507305200

Role of the Syk autophosphorylation site and SH2 domains in B cell antigen receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507305200

Syk deficiency--a knockout for B-cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507305200

Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and down-regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507305200

Syk expression and novel function in a wide variety of tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507305200

The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507305200

MMTV Env encodes an ITAM responsible for transformation of mammary epithelial cells in three-dimensional culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507305200

Syk expression in endothelial cells and their morphologic defects in embryonic Syk-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507305200

Epstein-barr virus-associated malignancies: epidemiologic patterns and etiologic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507305200

Antibodies to LMP2A/2B in EBV-carrying malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507305200

Epstein-Barr virus LMP2A transforms epithelial cells, inhibits cell differentiation, and activates Akt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507305200

Roles of the ITAM and PY motifs of Epstein-Barr virus latent membrane protein 2A in the inhibition of epithelial cell differentiation and activation of {beta}-catenin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507305200

Epstein-Barr virus latent membrane protein 2A regulates c-Jun protein through extracellular signal-regulated kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507305200

Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507305200

The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mediated signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507305200

Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507305200

Epstein-Barr virus latency: LMP2, a regulator or means for Epstein-Barr virus persistence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507305200

Analysis of the phosphorylation status of Epstein-Barr virus LMP2A in epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507305200

Characteristics of a human cell line transformed by DNA from human adenovirus type 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507305200

Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507305200

High-efficiency transformation of mammalian cells by plasmid DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507305200

Characterization of Monoclonal Antibodies to the Zta and DNase Proteins of Epstein-Barr Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507305200

Upregulation of tyrosine kinase TKT by the Epstein-Barr virus transactivator Zta

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507305200

Identification of the major sites of autophosphorylation of the murine protein-tyrosine kinase Syk

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507305200

Phosphorylation of Syk activation loop tyrosines is essential for Syk function. An in vivo study using a specific anti-Syk activation loop phosphotyrosine antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507305200

SH2 domains recognize specific phosphopeptide sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507305200

Activation of Syk protein tyrosine kinase through interaction with integrin beta cytoplasmic domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507305200

The N-terminal SH2 domains of Syk and ZAP-70 mediate phosphotyrosine-independent binding to integrin beta cytoplasmic domains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507305200

The cellular phenotype conditions Btk for cell survival or apoptosis signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507305200

BTK as a mediator of radiation-induced apoptosis in DT-40 lymphoma B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507305200

An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507305200

Epstein-Barr virus LMP2A-induced B-cell survival in two unique classes of EmuLMP2A transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507305200

Epstein-Barr virus LMP2A alters in vivo and in vitro models of B-cell anergy, but not deletion, in response to autoantigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507305200

A requirement for Syk in the activation of the microtubule-associated protein kinase/phospholipase A2 pathway by Fc epsilon R1 is not shared by a G protein-coupled receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507305200

FcgammaRIIA exogenously expressed in HeLa cells activates the mitogen-activated protein kinase cascade by a mechanism dependent on the endogenous expression of the protein tyrosine kinase Syk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507305200

Protein tyrosine kinase inhibitors: new treatment modalities?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507305200

21 January 2018

Identifiers

DOI

10.1074/JBC.M507305200

1 reference

19 September 2017

1 reference